(Q34582207)

3 August 2017

title

Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer (English)

1 reference

3 August 2017

1 reference

1 reference

Caroline Dive

6

0 references

Gordon C. Jayson

object named as

Gordon C Jayson

10

0 references

Alison Backen

3

object named as

Alison Backen

1 reference

3 August 2017

7

Cassandra Hodgkinson

1 reference

3 August 2017

Claire Cole

1

1 reference

3 August 2017

Sin Lau

2

1 reference

3 August 2017

Andrew Clamp

4

1 reference

3 August 2017

Graham Rushton

5

1 reference

3 August 2017

Rhona McVey

8

1 reference

3 August 2017

Henry Kitchener

9

1 reference

3 August 2017

language of work or name

1 reference

4 September 2010

1 reference

Cancer Biology and Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

10

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

495-504

1 reference

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Primary ovarian cancer chemotherapy: current standards of care

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Cisplatin: mode of cytotoxic action and molecular basis of resistance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

A competitive PCR-based method to measure human fibroblast growth factor receptor 1-4 (FGFR1-4) gene expression.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Induction of Mdm2 and enhancement of cell survival by bFGF.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Receptor specificity of the fibroblast growth factor family

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Basic fibroblast growth factor and receptor expression in human ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3040972

Fibroblast growth factors

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.5.12585

The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.5.12585

Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FCBT.10.5.12585

Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/20595807

12 December 2020

Induction of FGF receptor 2-IIIb expression and response to its ligands in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20595807

12 December 2020

HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20595807

12 December 2020

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20595807

12 December 2020

Identifiers

DOI

10.4161/CBT.10.5.12585

1 reference

3 August 2017

1 reference

3 August 2017

1 reference